Tracy Reed, DPM
Podiatrist · Saint Louis, MONPI 1871593178
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,483 of the $8,140 with a category attached, or 79.7%. 22 manufacturers reported payments, led by Nevro Corp. at 28.5% of the total. Reporting peaked in 2023 at $2,815 and has fallen 61.0% since, to $1,096 in 2025.
Across 166 payments — averaging $49.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$2K
- Treace Medical Concepts, Inc.$1K
- Kerecis Limited$1K
- Organogenesis Inc.$801
- Averitas Pharma Inc.$549
- Smith+Nephew$401
- plus $2K from 16 others
What the payments were for
- Travel & lodging$1,65620%
- Food & beverage$6,48380%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 32 | $2,316 |
| Treace Medical Concepts, Inc. | 10 | $1,168 |
| Kerecis Limited | 15 | $1,166 |
| Organogenesis Inc. | 26 | $801 |
| Averitas Pharma Inc. | 12 | $549 |
| Smith+Nephew | 24 | $401 |
| Paratek Pharmaceuticals, Inc. | 18 | $239 |
| Next Science LLC | 8 | $225 |
| Progenacare Global, LLC | 3 | $209 |
| Triad Life Sciences Inc. | 1 | $169 |
| Melinta Therapeutics, LLC | 3 | $160 |
| Medtronic | 2 | $127 |
| Globus Medical | 1 | $126 |
| Stryker | 2 | $118 |
| Angiodynamics, Inc. | 1 | $115 |
| Bone Support Inc. | 1 | $68 |
| Trice Medical, Inc. | 1 | $50 |
| Koya Medical, Inc. | 1 | $40 |
| Advanced Oxygen Therapy Inc. | 1 | $35 |
| Zimmer Biomet | 2 | $28 |
| Integra Lifesciences Corporation | 1 | $19 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$2,182
- Kerecis SurgiClose$2,177
- Senza$1,544
- Lapiplasty System$736
- Kerecis Omega3 SurgiClose$545
- Kerecis GraftGuide$544
- Qutenza$373
- InnovaMatrix AC$169
- VERSAJET II$125
- Baxdela$122
- Puraply Antimicrobial$116
- SurgX$110
- Xperience$110
- BlastX$110
- BIOskin$105
How this compares
$8,140 in reported general payments places this provider in the 85th percentile of 105 podiatrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 649 | $26,764 |
| SantylCollagenase Clostridium Hist. | 14 | $9,480 |
| Griseofulvin Ultramicrosize | 37 | $5,320 |
| Clotrimazole | 81 | $2,224 |
| Ciclopirox | 34 | $1,059 |
| Terbinafine Hcl | 129 | $939 |
| Triamcinolone Acetonide | 59 | $822 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $816 |
| Ammonium Lactate | 36 | $625 |
| Ketoconazole | 22 | $527 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 20 | $319 |
| Lidocaine | 14 | $275 |
| Clindamycin Hcl | 17 | $186 |
| Ibuprofen | 12 | $110 |
| Levofloxacin | 11 | $28 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $401 | $9,48014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 105 podiatrist providers in Missouri.
Other podiatrist in Saint Louis
- Kiera Benge-SheaSaint Louis$28K
- Neil ErmitanoSaint Louis$14K
- Daniel NarowitzSaint Louis$12K
- Jay MoradiaSaint Louis$11K
- Michael HoenigSaint Louis$5K
- Matthew ClaxtonSaint Louis$5K
- Caleb WhiteSaint Louis$4K
- Christopher ForsbachSaint Louis$3K
- Stephen SehySaint Louis$1K
- Michael HorwitzSaint Louis$899
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.